Iovance updates corporate presentation; no specific new data in filing text

IOVANCE BIOTHERAPEUTICS, INC.

Corporate presentation updated for August 2026; used at healthcare conferences and with analysts.
No specific financial results, guidance, or operational milestones disclosed in the filing.
Exhibit 99.1 (presentation) is referenced but its content is not available in the provided text.
Confidence in materiality is low due to lack of exhibit content.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.